Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir
Crossref DOI link: https://doi.org/10.1007/s40262-015-0334-7
Published Online: 2015-10-30
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mogalian, Erik
German, Polina
Kearney, Brian P.
Yang, Cheng Yong
Brainard, Diana
McNally, John
Moorehead, Lisa
Mathias, Anita
Text and Data Mining valid from 2015-10-30